Detalles de la búsqueda
1.
Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma.
Blood
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713888
2.
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(2): 139-150, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642080
3.
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Int J Cancer
; 152(2): 239-248, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082445
4.
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.
Br J Haematol
; 203(5): 792-802, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691005
5.
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Br J Haematol
; 188(6): 898-906, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31792945
6.
At what point are we on the way to optimally treat multiple myeloma patients over 75 years of age in 2023?
Adv Clin Exp Med
; 2023 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589225
7.
Isolated Progression of Multiple Myeloma into the Extramedullary Plasmacytoma of Dura Mater: A Case Report and Review of the Literature.
Biomedicines
; 11(4)2023 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37189843
8.
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group.
Adv Clin Exp Med
; 32(1): 131-136, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603138
9.
The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age.
Cancers (Basel)
; 15(13)2023 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444579
10.
Risk factors and causes of early mortality in patients with newly diagnosed multiple myeloma in a "real-world" study: experiences of the Polish Myeloma Group.
Pol Arch Intern Med
; 131(6): 527-534, 2021 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33908731
11.
Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group.
Leuk Lymphoma
; 60(2): 341-348, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29979097
12.
Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.
Pol Arch Intern Med
; 134(5)2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38747414
Resultados
1 -
12
de 12
1
Próxima >
>>